- Home
- HRTX vs OM Comparison
HRTX vs OM Comparison
Compare HRTX & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.35
HOLD
Current Price
$4.34
Company Overview
Basic Information| Metric | HRTX | OM |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.5M | 85.0M |
| IPO Year | 1987 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HRTX | OM |
|---|---|---|
| Price | $1.35 | $4.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.50 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 2.0M | 915.6K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $155,097,000.00 | $120,069,000.00 |
| Revenue This Year | $8.98 | $5.77 |
| Revenue Next Year | $11.57 | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.60 | 4.65 |
| 52 Week Low | $1.00 | $4.00 |
| 52 Week High | $2.68 | $25.35 |
Technical Indicators
Market Signals| Indicator | HRTX | OM |
|---|---|---|
| Relative Strength Index (RSI) | 69.75 | 25.75 |
| Support Level | $1.10 | $4.00 |
| Resistance Level | $1.14 | $4.97 |
| Average True Range (ATR) | 0.08 | 0.38 |
| MACD | 0.03 | 0.27 |
| Stochastic Oscillator | 95.89 | 24.11 |
Price Performance
Historical Comparison HRTX
OM
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.